Skip to main content

Table 5 Duration of Hospitalization (per 100 children)

From: A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection

Study

Treatment Group

Control Group

Groothuis 1993 (RSV-IGIV)

53.1

143.8

PREVENT 1997 (RSV-IGIV)

60

129

Simoes 1998 (RSV-IGIV)

72

107

IMPACT-RSV 1998 (Palivizumab)

36.4

62.6

Feltes 2003 (Palivizumab)

57.4

129